Massivemarkets

BIO

Bio-Rad Laboratories, Inc.Class A

NYSE · usd

—+5.08 (+1.35%)
As of 7:33:03 PM EST on Nov 4, 2026 · 15-minute delayed

Stock performance

How Bio-Rad Laboratories, Inc.Class A (BIO) stock has performed from one day to one year, with its 52-week range.

-0.25%
-$0.96 over 1D
$372.20$375.14$378.08$381.029:30 AM11:10 AM12:50 PM2:30 PM8:00 PM$379.29
1D
+1.35%
1W
-1.33%
1M
+3.03%
YTD
+25.41%
1Y
+23.96%
52-wk range
$236.73 – $396.23

Key statistics

Today's trading snapshot for BIO: day range, open, previous close, volume and market cap.

Day range
—
Open
—
Prev close
$379.99
Volume
0
Market cap
$10.16B
Shares out
21.68M

Valuation and profitability ratios: P/E, P/S, ROE

Valuation and profitability ratios for Bio-Rad Laboratories, Inc.Class A: P/E, P/S, P/B, ROE and more.

P/E
45.07
P/S
3.87
P/B
1.40
P/FCF
28.39
ROE
3.1%
ROA
2.2%
Debt/Equity
0.17
Div yield
0.00%

As of Nov 3, 2026

8-K filings

Material corporate events Bio-Rad Laboratories, Inc.Class A has disclosed to the SEC on Form 8-K.

  • Quarterly earningsNov 4, 2026

    On November 4, 2026, Bio-Rad Laboratories, Inc. (the "Company") announced its financial results for the quarter ended September 30, 2026.

  • Facility closureAug 4, 2026

    The restructuring plan impacts our operations and functions throughout the world and includes the elimination of certain positions, the consolidation of certain functions, and the closure of various facilities.

  • Investor presentationApr 30, 2026

    Also on April 30, 2026, the Company posted supplemental earnings materials with respect to its financial results for the quarter ended March 31, 2026 to its website (the "Supplemental Earnings Presentation"), which can be accessed at www.bio-rad.com in the Investor Relations section under the subheading "Events & Presentations".

  • Shareholder proposal outcomeApr 24, 2026

    The stockholder proposal regarding dual class capital structure was not approved since the proposal did not receive the affirmative vote of a majority of the voting power of the holders of Class A and Class B Common Stock.

  • Investor presentationFeb 12, 2026

    Also on February 12, 2026, the Company posted supplemental earnings materials with respect to its financial results for the quarter ended December 31, 2025 to its website (the "Supplemental Earnings Presentation"), which can be accessed at www.bio-rad.com in the Investor Relations section under the subheading "Events & Presentations."

BIO short interest

How heavily BIO is shorted: shares short, days to cover and average daily volume.

Days to cover
4.8
Short interest
1.1M
Avg volume
226.56K

As of · reported to FINRA twice monthly.

BIO news

The latest news and headlines about Bio-Rad Laboratories, Inc.Class A (BIO).

Frequently asked questions

What is the Bio-Rad Laboratories, Inc.Class A (BIO) stock price today?

Massive provides real-time and historical Bio-Rad Laboratories, Inc.Class A (BIO) quotes via REST API, WebSocket and MCP.

What is Bio-Rad Laboratories, Inc.Class A?

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets.

What is the short interest in BIO?

As of Oct 15, 2026, BIO has 1.1M shares short and 4.8 days to cover.

What exchange is BIO listed on?

Bio-Rad Laboratories, Inc.Class A (BIO) trades on NYSE in USD, in the LABORATORY ANALYTICAL INSTRUMENTS industry.

Build with AI

Build an analysis of BIO with your agent

Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.

Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a BIO analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.

Live market data from the Massive API and MCP.Get a free API key

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.